Recent Quotes (30 days)

You have no recent quotes
chg | %

Theratechnologies Inc  

(Public, TSE:TH)   Watch this stock  
Find more results for TH
-0.01 (-0.67%)
Delayed:   9:49AM EST
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.47 - 1.49
52 week 0.32 - 2.72
Open 1.49
Vol / Avg. 7,062.00/127,723.00
Mkt cap 97.77M
P/E     -
Div/yield     -
EPS -0.04
Shares 65.62M
Beta 0.43
Inst. own     -
Feb 24, 2016
Q4 2015 Theratechnologies Inc Earnings Release (Estimated) Add to calendar
Oct 1, 2015
Q3 2015 Theratechnologies Inc Earnings Call - Webcast
Oct 1, 2015
Q3 2015 Theratechnologies Inc Earnings Release

Key stats and ratios

Q3 (Aug '15) 2014
Net profit margin 12.82% -156.58%
Operating margin 22.06% -191.16%
EBITD margin - -174.20%
Return on average assets 10.51% -36.67%
Return on average equity 34.27% -79.87%
Employees 19 -
CDP Score - -


2015 Peel St 5th Floor
+1-514-3367800 (Phone)
+1-514-3319691 (Fax)

Website links


Theratechnologies Inc. is a specialty pharmaceutical company addressing unmet medical needs in metabolic disorders to promote healthy ageing. The Company's product, EGRIFTA, is used for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy. EGRIFTATM is available in the United States as a once-daily two unit dose (two vials, each containing 1 milligram of tesamorelin) of sterilized lyophilized powder to be reconstituted with sterile water for injection. Its subsidiaries include Theratechnologies Intercontinental Inc., Theratechnologies Europe Inc., Theratechnologies Canada Inc. and Pharma-G Inc.

Officers and directors

Dawn Svoronos Independent Chairman of the Board
Age: 61
Luc Tanguay President, Chief Executive Officer, Director
Age: 56
Lyne Fortin Senior Vice President, Chief Commercial Officer
Age: 55
Christian Marsolais Ph.D. Senior Vice President - Scientific Affairs and Alliances
Age: 52
Marie-Noel Colussi Vice President - Finance
Age: 46
Jocelyn Lafond Vice President - Legal Affairs, Corporate Secretary
Age: 47
Pierre Perazzelli Vice President - Pharmaceutical Development
Age: 63
Gilles Cloutier Ph.D. Independent Director
Age: 70
Gerald A Lacoste Independent Director
Age: 71
Paul Pommier Independent Director
Age: 72